{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:07:24Z","timestamp":1790813244068,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer US","isbn-type":[{"value":"9781071627716","type":"print"},{"value":"9781071627723","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_22","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"427-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon Skipping"],"prefix":"10.1007","author":[{"given":"Kei","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitsu","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","DOI":"10.1126\/science.1225829"},{"key":"22_CR2","doi-asserted-by":"crossref","unstructured":"Knott GJ, Doudna JA CRISPR-Cas guides the future of genetic engineering. Science 361:866\u2013869","DOI":"10.1126\/science.aat5011"},{"issue":"1","key":"22_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","volume":"4","author":"HL Li","year":"2015","unstructured":"Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T et al (2015) Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep 4(1):143\u2013154","journal-title":"Stem Cell Rep"},{"issue":"6271","key":"22_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E et al (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351(6271):400\u2013403","journal-title":"Science"},{"issue":"6271","key":"22_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM et al (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351(6271):403\u2013407","journal-title":"Science"},{"issue":"6410","key":"22_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","volume":"362","author":"L Amoasii","year":"2018","unstructured":"Amoasii L, Hildyard JCW, Li H, Sanchez-Ortiz E, Mireault A, Caballero D et al (2018) Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science 362(6410):86\u201391","journal-title":"Science"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1182\/blood-2011-09-382317","volume":"119","author":"G Buchlis","year":"2012","unstructured":"Buchlis G, Podsakoff GM, Radu A, Hawk SM, Flake AW, Mingozzi F et al (2012) Brief report Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer. Blood 119:3038\u20133041","journal-title":"Blood"},{"issue":"9","key":"22_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK et al (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31(9):822\u2013826","journal-title":"Nat Biotechnol"},{"issue":"3","key":"22_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD et al (2019) Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat Med 25(3):427\u2013432","journal-title":"Nat Med"},{"issue":"4","key":"22_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N et al (2019) Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24(4):566\u2013578.e7","journal-title":"Cell Stem Cell"},{"issue":"6","key":"22_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim S, Kim D, Cho SW, Kim J, Kim JS (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24(6):1012\u20131019","journal-title":"Genome Res"},{"issue":"4","key":"22_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.stemcr.2021.02.013","volume":"16","author":"A Kagita","year":"2021","unstructured":"Kagita A, Lung MSY, Xu H, Kita Y, Sasakawa N, Iguchi T et al (2021) Efficient ssODN-mediated targeting by avoiding cellular inhibitory RNAs through precomplexed CRISPR-Cas9\/sgRNA ribonucleoprotein. Stem Cell Rep 16(4):985\u2013996","journal-title":"Stem Cell Rep"},{"issue":"7","key":"22_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/gt.2016.27","volume":"23","author":"JG Choi","year":"2016","unstructured":"Choi JG, Dang Y, Abraham S, Ma H, Zhang J, Guo H et al (2016) Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther 23(7):627\u2013633","journal-title":"Gene Ther"},{"issue":"1","key":"22_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J et al (2019) Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun 10(1):1\u201315","journal-title":"Nat Commun"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","volume":"12","author":"C Montagna","year":"2018","unstructured":"Montagna C, Petris G, Casini A, Maule G, Franceschini GM, Zanella I et al (2018) VSV-G-enveloped vesicles for traceless delivery of CRISPR-Cas9. Mol Ther Nucleic Acids 12:453\u2013462","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"22_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymthe.2018.10.002","volume":"27","author":"LA Campbell","year":"2019","unstructured":"Campbell LA, Coke LM, Richie CT, Fortuno LV, Park AY, Harvey BK (2019) Gesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex for inactivating the HIV Provirus. Mol Ther 27(1):151\u2013163","journal-title":"Mol Ther"},{"issue":"1","key":"22_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y et al (2020) Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun 11(1):1\u201318","journal-title":"Nat Commun"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.febslet.2012.04.061","volume":"586","author":"M Putyrski","year":"2012","unstructured":"Putyrski M, Schultz C (2012) Protein translocation as a tool: the current rapamycin story. FEBS Lett 586:2097\u20132105","journal-title":"FEBS Lett"},{"issue":"1","key":"22_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2005.10.017","volume":"13","author":"JH Bayle","year":"2006","unstructured":"Bayle JH, Grimley JS, Stankunas K, Gestwicki JE, Wandless TJ, Crabtree GR (2006) Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity. Chem Biol 13(1):99\u2013107","journal-title":"Chem Biol"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep18341","volume":"5","author":"S Yoshioka","year":"2015","unstructured":"Yoshioka S, Fujii W, Ogawa T, Sugiura K, Naito K (2015) Development of a mono-promoter-driven CRISPR\/Cas9 system in mammalian cells. Sci Rep 5:1\u20138","journal-title":"Sci Rep"},{"key":"22_CR21","first-page":"a003574","volume":"2","author":"AR Ferr\u00e9-D\u2019Amar\u00e9","year":"2010","unstructured":"Ferr\u00e9-D\u2019Amar\u00e9 AR, Scott WG (2010) Small self-cleaving ribozymes. Cold Spring Harb Perspect Biol 2:a003574","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"22_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03432-4","volume":"9","author":"J Nikolic","year":"2018","unstructured":"Nikolic J, Belot L, Raux H, Legrand P, Gaudin Y, Albertini AA (2018) Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. Nat Commun 9(1):1\u201312","journal-title":"Nat Commun"}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:07:55Z","timestamp":1677654475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}